Showing all 2 results
Artesunate & Amodiaquine Tablets
FreeProduct Composition & Available Strengths
We supply this product in both modern co-formulated Fixed-Dose Combination (FDC) single tablets and customized co-blistered kits, accurately titrated for adult and pediatric compliance.
Formulation Format Active Ingredient Mix (per Dose) Target Patient Segment Primary Clinical Function Infant / Pediatric FDC 25 mg Artesunate + 67.5 mg Amodiaquine Infants (2 months to less than 1 year) Early Intervention: Specially sized for pediatric dispersal. Toddler / Child FDC 50 mg Artesunate + 135 mg Amodiaquine Children (1 year to less than 6 years) Growth Tier: Optimized for easy pediatric administration. Youth / Adolescent FDC 100 mg Artesunate + 270 mg Amodiaquine Adolescents (6 years to less than 14 years) Intermediate Tier: Ensures accurate dosing for older children. Adult Potency FDC 100 mg + 270 mg (2 Tablets/Day) or 200 mg + 540 mg Adults & Children over 14 years Full Strength: Complete 3-day treatment matrix. Artesunate & Mefloquine Tablet
FreeProduct Composition & Compliance Configurations
We supply this combination in both co-formulated Fixed-Dose Combination (FDC) single tablets and customized, color-coded co-blistered kits calibrated for adult and pediatric treatment regimens.
Product Packaging Format Active Ingredient Mix (per Dose) Target Patient Cohort Primary Clinical Function Pediatric Compliance FDC 25 mg Artesunate + 55 mg Mefloquine Infants & Children (6 months to less than 7 years) Micro-Dose Accuracy: Optimized for easy pediatric disintegration and ingestion. Adolescent Strength FDC 100 mg Artesunate + 220 mg Mefloquine Youth & Teenagers (7 years to less than 14 years) Intermediate Titration: Ensures balanced dosing without neuro-toxicity risks. Adult Potency FDC / Kit 100 mg + 220 mg (2 Tablets/Day for 3 days) or 200 mg + 440 mg Adults & Children over 14 years Full Strength Treatment: Maximizes biomass eradication in multi-drug resistant zones.
